Clinical Trial Update: Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fondaparinux for treating heparin-induced thrombocytopenia has been terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia

Drugs mentioned

• Fondaparinux (fondaparinux)

Snippet

Sponsor: University of Louisville | Conditions: Heparin-Induced Thrombocytopenia | Phase 2 | Status: TERMINATED | Results posted: 2013-06-24